Your privacy is very important to us. When you visit our website, please agree to the use of all cookies. For more information about personal data processing, please go to Privacy Policy.

Pipeline

Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation epigenetic engineering therapy utilizing regulation of epigenetic genome for a variety of diseases. The company has multiple pipeline projects, including treatment for metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.

  • Area
  • Pipeline Program
  • Discovery
  • Mouse、NHP POC
  • IIT/IND
  • Phase I
Metabolic/liver diseases
  • Hypercholesterolemia (EPI-001)
    • c2_icon01.svg
  • Hepatitis B, HBV (EPI-003)
    • c2_icon01.svg
  • Not disclosed
    • c2icon02.svg
  • Not disclosed
    • c2icon02.svg
  • Not disclosed
    • c2icon02.svg
Ophthalmology disorders
  • Not disclosed
    • c2_icon03.svg
CNS disorders
  • Not disclosed
    • c2_icon03.svg
  • Not disclosed
    • c2_icon02.svg
Oncoimmunology
  • CAR-T
    • c2_icon03.svg
      Partnership
    • Therapeutic areas
    • Pipeline projects
    Metabolic/liver diseases
    Hypercholesterolemia (EPI-001)
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2_icon01.svg
    • Therapeutic areas
    • Pipeline projects
    Metabolic/liver diseases
    Hepatitis B, HBV (EPI-003)
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2_icon01.svg
    • Therapeutic areas
    • Pipeline projects
    Metabolic/liver diseases
    Not disclosed
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2icon02.svg
    • Therapeutic areas
    • Pipeline projects
    Metabolic/liver diseases
    Not disclosed
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2icon02.svg
    • Therapeutic areas
    • Pipeline projects
    Metabolic/liver diseases
    Not disclosed
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2icon02.svg
    • Therapeutic areas
    • Pipeline projects
    Ophthalmology disorders
    Not disclosed
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2_icon03.svg
    • Therapeutic areas
    • Pipeline projects
    CNS disorders
    Not disclosed
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2_icon03.svg
    • Therapeutic areas
    • Pipeline projects
    CNS disorders
    Not disclosed
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2_icon02.svg
    • Therapeutic areas
    • Pipeline projects
    Oncoimmunology
    CAR-T
    • Drug discovery
    • POC (mice, NHP)
    • IIT / IND
    • Phase I
    • c2_icon03.svg
      Partnership